|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Kaiser Permanente Mentor Corporation |
| Information provided by: | Kaiser Permanente |
| ClinicalTrials.gov Identifier: | NCT00495534 |
Purpose
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) occasionally requires post-approval studies to help monitor the safety, effectiveness, and reliability of the approved device for its intended use. These studies are conducted under an FDA-approved protocol with the intended purpose of gathering specific additional information about the marketed device.
| Condition | Intervention |
|
Postoperative Complications Mammaplasty |
Device: Mentor MemoryGel Silicone Gel-filled breast implants |
| MedlinePlus related topics: | Breast Reconstruction |
| Study Type: | Observational |
| Study Design: | Case-Only, Prospective |
| Official Title: | Memorygel™ Postapproval Study Of Mentor Memorygel Breast Implants In Women Undergoing Breast Augmentation Or Reconstruction |
| Estimated Enrollment: | 42900 |
| Study Start Date: | March 2007 |
| Estimated Study Completion Date: | December 2017 |
As a condition of gaining access to the approved silicone gel filled breast implants, the first 41,900 women will participate in the 10 year study. In addition, there will be a concurrent control group of 1000 women with saline filled breast implants to serve as concurrent controls for assessing rheumatologic and neurologic signs and symptoms. The study methods include a baseline questionnaire, a device tracking form, a visit at one year post-op, a visit at four to six years post-op, a visit nine to ten years post-op, and the questionnaire at the time of any participants discontinuation (when possible).
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
members and nonmembers of the Kaiser Foundation Health Plan who present for implantation of the Mentor Silicone Gel-filled breast implant at a Kaiser Permanente medical facility in Northern California
MemoryGel Breast Implant Participants
Inclusion Criteria:
Must be a woman who
Exclusion Criteria:
Saline Breast Implant Control Participants
Inclusion Criteria:
Exclusion criteria:
Contacts and Locations| Contact: Harold R Mancusi-Ungaro, M.D. | 707-571-4405 | harold.mancusi-ungaro@kp.org |
| Contact: Lila Schwartz, J.D. | 510-65-3875 | lila.schwartz@kp.org |
| United States, California | |||||
| Kaiser Permanente | Recruiting | ||||
| Sacramento, California, United States, 95825-2115 | |||||
| Contact: Kenneth O Phillips, M.D. 916-973-7354 kenneth.o.phillips@kp.org | |||||
| Contact: Alexander R Vento, M.D. 916-973-7353 alexander.vento@kp.org | |||||
| Kaiser Permanente | Recruiting | ||||
| Santa Rosa, California, United States, 95403 | |||||
| Contact: Harold R Mancusi-Ungaro, M.D. 707-571-4405 harold.mancusi-ungaro@kp.org | |||||
| Contact: Eric Y Lin, M.D. 707-571-4885 eric.y.lin@kp.org | |||||
| Kaiser Permanente | Recruiting | ||||
| Oakland, California, United States, 94611-5642 | |||||
| Contact: Benjamin M Hornik, M.D. 510-752-6413 benjamin.hornik@kp.org | |||||
| Kaiser Permanente | Recruiting | ||||
| Napa, California, United States, 94558 | |||||
| Contact: Mark A Price, M.D. 707-258-4407 mark.a.price@kp.org | |||||
| Kaiser Permanente | Recruiting | ||||
| Richmond, California, United States, 94801-3143 | |||||
| Contact: Karen M Yokoo, M.D. 510-307-2519 karen.yokoo@kp.org | |||||
| Contact: Hop N Le, M.D. 510-307-2482 hop.le@kp.org | |||||
| Kaiser Permanente |
| Mentor Corporation |
| Study Chair: | William Strull, M.D. | Kaiser Permanente Northern California Biomedical Institutional Review Board |
More Information
Mentor MemoryGel Home Page 
  |
| Responsible Party: | Mentor Corporation ( Ms. Nou Moua ) |
| Study ID Numbers: | CN-07HManc-01-B |
| First Received: | July 2, 2007 |
| Last Updated: | January 24, 2008 |
| ClinicalTrials.gov Identifier: | NCT00495534 |
| Health Authority: | United States: Institutional Review Board |
|
|
|